Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease.

Baillargeon J, Wang Y, Kuo YF, Holmes HM, Sharma G.

Am J Med. 2013 Jul;126(7):607-14. doi: 10.1016/j.amjmed.2013.01.035.

2.

Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.

Genao L, Durheim MT, Mi X, Todd JL, Whitson HE, Curtis LH.

Ann Am Thorac Soc. 2015 Dec;12(12):1805-12. doi: 10.1513/AnnalsATS.201504-250OC.

3.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

4.

Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.

Simoni-Wastila L, Wei YJ, Qian J, Zuckerman IH, Stuart B, Shaffer T, Dalal AA, Bryant-Comstock L.

Am J Geriatr Pharmacother. 2012 Jun;10(3):201-10. doi: 10.1016/j.amjopharm.2012.04.002.

PMID:
22521808
5.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
6.

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Chen J, Normand SL, Wang Y, Krumholz HM.

JAMA. 2011 Oct 19;306(15):1669-78. doi: 10.1001/jama.2011.1474.

7.

COPD surveillance--United States, 1999-2011.

Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH.

Chest. 2013 Jul;144(1):284-305. doi: 10.1378/chest.13-0809.

8.

Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.

Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS.

Arch Intern Med. 2010 Oct 11;170(18):1664-70. doi: 10.1001/archinternmed.2010.345.

9.

Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.

Qian J, Simoni-Wastila L, Rattinger GB, Zuckerman IH, Lehmann S, Wei YJ, Stuart B.

Int J Geriatr Psychiatry. 2014 Jan;29(1):49-57. doi: 10.1002/gps.3968.

10.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997.

11.

Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.

Singh G, Zhang W, Kuo YF, Sharma G.

Chest. 2016 Apr;149(4):905-15. doi: 10.1378/chest.15-0449.

PMID:
26204260
12.

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA.

Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157.

PMID:
19778165
13.

Impact of comorbidity on mortality among older persons with advanced heart failure.

Ahluwalia SC, Gross CP, Chaudhry SI, Ning YM, Leo-Summers L, Van Ness PH, Fried TR.

J Gen Intern Med. 2012 May;27(5):513-9. doi: 10.1007/s11606-011-1930-3. Erratum in: J Gen Intern Med. 2012 Sep;27(9):1228-30.

14.

National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010.

Wang Y, Schrag D, Brooks GA, Dominici F.

Cancer. 2014 Apr 1;120(7):1050-8. doi: 10.1002/cncr.28537.

15.

Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.

Krumholz HM, Nuti SV, Downing NS, Normand SL, Wang Y.

JAMA. 2015 Jul 28;314(4):355-65. doi: 10.1001/jama.2015.8035. Erratum in: JAMA. 2015 Aug 25;314(8):837.

PMID:
26219053
16.

Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges.

Chen J, Normand SL, Wang Y, Drye EE, Schreiner GC, Krumholz HM.

Circulation. 2010 Mar 23;121(11):1322-8. doi: 10.1161/CIRCULATIONAHA.109.862094.

17.

Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States.

Holt JB, Zhang X, Presley-Cantrell L, Croft JB.

Int J Chron Obstruct Pulmon Dis. 2011;6:321-8. doi: 10.2147/COPD.S19945.

18.

Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.

Moll K, Sun SX, Ellis JJ, Howe A, Amin A.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:565-76. doi: 10.2147/COPD.S79025.

19.

Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics.

O'Malley AS, Pham HH, Schrag D, Wu B, Bach PB.

Med Care. 2007 Jun;45(6):562-70.

PMID:
17515784
20.

National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.

Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, Huang ES, Desai MM, Gill TM, Krumholz HM.

JAMA Intern Med. 2014 Jul;174(7):1116-24. doi: 10.1001/jamainternmed.2014.1824.

Items per page

Supplemental Content

Support Center